Tibet AIM Pharm. Inc. (SHE:002826)
China · Delayed Price · Currency is CNY 19.50
-0.02 (-0.10%)
Apr 30, 2026, 3:04 PM CST
Tibet AIM Pharm. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 93.98 | 93.12 | 45.93 | 15.39 | 44.14 | 42.48 |
Depreciation & Amortization | 19.14 | 19.14 | 21.55 | 24.14 | 22.7 | 23.74 |
Other Amortization | - | - | 0.14 | 1.78 | 1.78 | 1.78 |
Loss (Gain) From Sale of Assets | 0.23 | 0.23 | 0.04 | -0.03 | - | -0.03 |
Asset Writedown & Restructuring Costs | 2.76 | 2.76 | 0.2 | 19.93 | 0.08 | 0.08 |
Loss (Gain) From Sale of Investments | -3.5 | -3.5 | -3.51 | -2.31 | -1.48 | -0.91 |
Provision & Write-off of Bad Debts | - | - | 0.67 | -7.02 | 6.64 | -1.13 |
Other Operating Activities | 46.57 | -1.08 | 2.5 | 0.39 | -0.36 | -1.03 |
Change in Accounts Receivable | 26.55 | 26.55 | -14.57 | 170.44 | 6.1 | 86.19 |
Change in Inventory | -18.74 | -18.74 | 17.63 | -13.42 | -12.09 | -12.52 |
Change in Accounts Payable | 8.84 | 8.84 | -8.53 | -46.74 | 47.54 | -52.44 |
Change in Other Net Operating Assets | -1.78 | -1.78 | 48.01 | 3.04 | -43.92 | 19.75 |
Operating Cash Flow | 172.22 | 123.72 | 111.57 | 166.88 | 68.45 | 109.52 |
Operating Cash Flow Growth | 94.16% | 10.89% | -33.14% | 143.79% | -37.50% | 7.65% |
Capital Expenditures | -8.83 | -8.5 | -12.24 | -3.18 | -3.2 | -25.2 |
Sale of Property, Plant & Equipment | 0.17 | 0.15 | 0.14 | 0.08 | 0 | 0.06 |
Cash Acquisitions | - | - | - | - | - | -29.45 |
Investment in Securities | - | - | 28.54 | -42.14 | - | - |
Other Investing Activities | 6.58 | 6.51 | 2.56 | 2.24 | 1.48 | 0.91 |
Investing Cash Flow | -2.09 | -1.84 | 19 | -43 | -1.72 | -53.68 |
Short-Term Debt Issued | - | - | 22.8 | 11 | 50 | - |
Long-Term Debt Issued | - | 22.11 | - | - | - | - |
Total Debt Issued | 9.61 | 22.11 | 22.8 | 11 | 50 | - |
Short-Term Debt Repaid | - | - | -11 | -50 | - | -40 |
Long-Term Debt Repaid | - | -33.66 | - | - | - | -0.09 |
Total Debt Repaid | -44.91 | -33.66 | -11 | -50 | - | -40.09 |
Net Debt Issued (Repaid) | -35.3 | -11.55 | 11.8 | -39 | 50 | -40.09 |
Repurchase of Common Stock | - | - | -50.03 | -0.02 | -2.64 | -3.01 |
Common Dividends Paid | -23.66 | -23.84 | -6.04 | -20.28 | -19.77 | -15.27 |
Other Financing Activities | 30.97 | 24.51 | - | - | - | -0.83 |
Financing Cash Flow | -27.99 | -10.88 | -44.26 | -59.3 | 27.59 | -59.2 |
Foreign Exchange Rate Adjustments | -1.11 | -0.73 | 0.24 | -0 | -0.02 | -0.02 |
Net Cash Flow | 141.03 | 110.27 | 86.54 | 64.57 | 94.31 | -3.38 |
Free Cash Flow | 163.39 | 115.22 | 99.33 | 163.7 | 65.26 | 84.33 |
Free Cash Flow Growth | 103.00% | 16.00% | -39.32% | 150.86% | -22.62% | 33.20% |
Free Cash Flow Margin | 24.38% | 18.11% | 15.24% | 24.54% | 7.62% | 11.62% |
Free Cash Flow Per Share | 0.89 | 0.62 | 0.54 | 0.85 | 0.34 | 0.44 |
Cash Interest Paid | - | - | - | - | - | 0.83 |
Cash Income Tax Paid | 102.8 | 98.06 | 96.36 | 95.33 | 86.77 | 86.95 |
Levered Free Cash Flow | 167.73 | 109.58 | 22.04 | 135.69 | 88.29 | 12.88 |
Unlevered Free Cash Flow | 167.73 | 109.58 | 22.32 | 136.43 | 88.8 | 13.41 |
Change in Working Capital | 13.04 | 13.04 | 44.05 | 114.62 | -5.04 | 44.54 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.